This finding aligns with existing literature, which indicates that CD4+ and CD8+ T‐cell responses in convalescent COVID‐19 patients or recipients of the COVID‐19 mRNA vaccines were not significantly impacted by mutations present in SARS‐CoV‐2 variants.72 The gene discussed is CD8A; the disease is COVID-19.